Cargando…

Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma

BACKGROUND: Epigenetic inactivation of tumor suppressor genes (TSG) by promoter CpG island hypermethylation is a hallmark of cancer. To assay its extent in human lymphoma, methylation of 24 TSG was analyzed in lymphoma-derived cell lines as well as in patient samples. METHODS: We screened for TSG me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eberth, Sonja, Schneider, Björn, Rosenwald, Andreas, Hartmann, Elena M, Romani, Julia, Zaborski, Margarete, Siebert, Reiner, Drexler, Hans G, Quentmeier, Hilmar
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955612/ https://www.ncbi.nlm.nih.gov/pubmed/20920234 http://dx.doi.org/10.1186/1471-2407-10-517

Ejemplares similares

BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance
por: Quentmeier, Hilmar, et al.
Publicado: (2011)

CD7 in acute myeloid leukemia: correlation with loss of wild-type CEBPA, consequence of epigenetic regulation
por: Röhrs, Sonja, et al.
Publicado: (2010)

DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4)
por: Quentmeier, Hilmar, et al.
Publicado: (2012)

SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines
por: Quentmeier, Hilmar, et al.
Publicado: (2009)

There is a Scientific Need for the Right Leukemia-Lymphoma Cell Lines
por: Drexler, Hans G., et al.
Publicado: (2019)

RBFOX2 and alternative splicing in B-cell lymphoma
por: Quentmeier, Hilmar, et al.
Publicado: (2018)

Inhibition of MCL1 induces apoptosis in anaplastic large cell lymphoma and in primary effusion lymphoma
por: Quentmeier, Hilmar, et al.
Publicado: (2022)

Suitability of Yin Yang 1 transcript and protein levels for biomarker studies in B cell non-Hodgkin lymphoma
por: Arribas Arranz, Jéssica, et al.
Publicado: (2018)

Inhibition of PI3K/mTOR Overcomes Nilotinib Resistance in BCR-ABL1 Positive Leukemia Cells through Translational Down-Regulation of MDM2
por: Ding, Jie, et al.
Publicado: (2013)

The LL-100 Cell Lines Panel: Tool for Molecular Leukemia–Lymphoma Research
por: Drexler, Hans G., et al.
Publicado: (2020)

Subclones in B-lymphoma cell lines: isogenic models for the study of gene regulation
por: Quentmeier, Hilmar, et al.
Publicado: (2016)

Downregulation of STAT3 in Epstein-Barr Virus-Positive Hodgkin Lymphoma
por: Nagel, Stefan, et al.
Publicado: (2022)

T‐cell‐derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma
por: Bein, Julia, et al.
Publicado: (2022)

The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma
por: Paczkowska, Julia, et al.
Publicado: (2020)

Enhanced whole exome sequencing by higher DNA insert lengths
por: Pommerenke, Claudia, et al.
Publicado: (2016)

Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing
por: Quentmeier, Hilmar, et al.
Publicado: (2016)

Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas
por: Hartmann, Sylvia, et al.
Publicado: (2021)

A case of nodular lymphocyte predominant Hodgkin lymphoma with unexpected EBV-latency type
por: Rosenfeldt, Mathias T., et al.
Publicado: (2020)

Targeting CD47-SIRPα axis for Hodgkin and non-Hodgkin lymphoma immunotherapy
por: Zhao, Pengcheng, et al.
Publicado: (2023)

Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma
por: Nagel, Stefan, et al.
Publicado: (2015)

Aberrant expression of NKL homeobox gene HLX in Hodgkin lymphoma
por: Nagel, Stefan, et al.
Publicado: (2018)

P043: Molecular pathogenesis of Hodgkin lymphoma
por: Beeck, Lilian, et al.
Publicado: (2022)

Identification of two unannotated miRNAs in classic Hodgkin lymphoma cell lines
por: Ustaszewski, Adam, et al.
Publicado: (2023)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Association of HHV-6 with Hodgkin and non Hodgkin lymphoma
por: Kiani, Hadis, et al.
Publicado: (2016)

Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

Pathobiology of Hodgkin Lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2011)

Pathobiology of Hodgkin Lymphoma
por: Agostinelli, Claudio, et al.
Publicado: (2014)

Cutaneous Hodgkin's lymphoma
por: Ambekar, Asawari Anant, et al.
Publicado: (2017)

Checkpoint CD47 expression in classical Hodgkin lymphoma
por: Gholiha, Alex Reza, et al.
Publicado: (2022)

The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
por: Dogan, Ahmet
Publicado: (2022)

CD20 Over-Expression in Hodgkin-Reed-Sternberg Cells of Classical Hodgkin Lymphoma: the Neglected Quest
por: Benharroch, Daniel, et al.
Publicado: (2015)

Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
por: Grover, Natalie S., et al.
Publicado: (2015)

Association of Human Cytomegalovirus with Hodgkin’s Disease and Non-Hodgkin’s lymphomas
por: Mehravaran, Hamide, et al.
Publicado: (2017)

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
por: Barrington, Sally F., et al.
Publicado: (2017)

Hodgkin Reed–Sternberg-Like Cells in Non-Hodgkin Lymphoma
por: Parente, Paola, et al.
Publicado: (2020)

Genetic and epigenetic variants in the MTHFR gene are not associated with non-Hodgkin lymphoma
por: Bradshaw, Gabrielle, et al.
Publicado: (2015)

NKL homeobox gene NKX2-2 is aberrantly expressed in Hodgkin lymphoma
por: Nagel, Stefan, et al.
Publicado: (2018)

Hodgkin-Reed-Sternberg Cells in Classical Hodgkin Lymphoma Show Alterations of Genes Encoding the NADPH Oxidase Complex and Impaired Reactive Oxygen Species Synthesis Capacity
por: Giefing, Maciej, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1huku7mcteq1lv8ne1hdc7m7lo